Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,084 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity-Does it matter?
Tütüncü M, Demir S, Arslan G, Dinç Ö, Şen S, Gündüz T, Uzunköprü C, Gümüş H, Tütüncü M, Akçin R, Özakbaş S, Köseoğlu M, Bünül SD, Gezen O, Tezer DÇ, Baba C, Özen PA, Koç R, Elverdi T, Uygunoğlu U, Kürtüncü M, Beckmann Y, Doğan İG, Turan ÖF, Boz C, Terzi M, Tuncer A, Saip S, Karabudak R, Kocazeybek B, Efendi H, Bilge U, Siva A. Tütüncü M, et al. Among authors: sen s. Mult Scler Relat Disord. 2023 Jul;75:104761. doi: 10.1016/j.msard.2023.104761. Epub 2023 May 10. Mult Scler Relat Disord. 2023. PMID: 37247488 Free PMC article.
Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial.
Ozakbas S, Turkoglu R, Tamam Y, Terzi M, Taskapilioglu O, Yucesan C, Baser HL, Gencer M, Akil E, Sen S, Turan OF, Sorgun MH, Yigit P, Turkes N. Ozakbas S, et al. Among authors: sen s. Mult Scler Relat Disord. 2018 May;22:70-76. doi: 10.1016/j.msard.2018.03.009. Epub 2018 Mar 24. Mult Scler Relat Disord. 2018. PMID: 29605801
'Is RLS a harbinger and consequence of MS?: Striking results of the 'RELOMS-T' study'.
Sevim S, Demirkıran M, Terzi M, Yüceyar N, Taşdelen B, İdiman E, Kürtüncü M, Boz C, Tuncel D, Karabudak R, Siva A, Özcan A, Neyal M, Göksel BK, Balal M, Şen S, Ekmekçi Ö, Öksüz N, Kaya D. Sevim S, et al. Among authors: sen s. Mult Scler Relat Disord. 2020 Jul;42:102055. doi: 10.1016/j.msard.2020.102055. Epub 2020 Mar 16. Mult Scler Relat Disord. 2020. PMID: 32473575
The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey.
Uzunköprü C, Tütüncü M, Gündüz T, Gümüş H, Şen S, Demir S, Çınar BP, Türe HS, Uygunoğlu U, Toğrol RE, Terzi M, Kürtüncü M, Özakbaş S, Tütüncü M, Beckmann Y, Siva A. Uzunköprü C, et al. Among authors: sen s. Int J Clin Pract. 2021 Jul;75(7):e14158. doi: 10.1111/ijcp.14158. Epub 2021 Apr 8. Int J Clin Pract. 2021. PMID: 33743552
The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?
Sen S, Karabudak R, Schiavetti I, Demir S, Ozakbas S, Tutuncu M, Petek Balci B, Turan OF, Uzunkopru C, Koseoglu M, Yetkin MF, Gunduz T, Gumus H, Kale Icen N, Carmisciano L, Terzi M, Acar P, Gungor Dogan I, Baba C, Tuncer A, Uygunoglu U, Sormani MP, Efendi H, Siva A; Turkish MS Study Group. Sen S, et al. Mult Scler Relat Disord. 2021 Jul;52:102968. doi: 10.1016/j.msard.2021.102968. Epub 2021 Apr 18. Mult Scler Relat Disord. 2021. PMID: 33940495 Free PMC article.
A comprehensive assessment of patient experience and disease-related awareness in multiple sclerosis: A questionnaire-based nation-wide survey in Turkey.
Demir S, Tutuncu M, Uzunkopru C, Gumus H, Sen S, Gunduz T, Dogan IG, Cinar BP, Incirli SU, Tutuncu M, Mavi K, Yuksel S, Togrol RE, Kocaman AS, Siva A. Demir S, et al. Among authors: sen s. Mult Scler Relat Disord. 2021 Jul;52:103005. doi: 10.1016/j.msard.2021.103005. Epub 2021 May 7. Mult Scler Relat Disord. 2021. PMID: 34000682
5,084 results